Top Markets
Coin of the day
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Rangering i aksjer #31786
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Aksjekurs
$0.21291741
Sist synkronisert: 2025-04-18
Markedsverdi
$12.07M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
KR
Handel PCL, Inc. (241820)

Kategori

Inntekter for PCL, Inc. (241820)
Inntekter i Sep 2025 TTM: $3.55M
Ifølge de nyeste økonomiske rapportene til PCL, Inc. er selskapets nåværende inntekter (TTM) $3.55M. I 2023 hadde selskapet inntekter på $6.51M en nedgang sammenlignet med inntektene i 2022, som var $29.49M. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for PCL, Inc. fra 2015 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $3.55M 318.67%
2024 $847.63K -86.98%
2023 $6.51M -77.92%
2022 $29.49M -24.02%
2021 $38.82M -21.50%
2020 $49.45M 159,346.74%
2019 $31.01K -73.14%
2018 $115.44K -75.69%
2017 $474.92K -2.74%
2016 $488.29K 136.13%
2015 $206.79K 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$46.59B 1,312,601.74%
US
$25.84B 727,951.41%
US
$35.48B 999,790.71%
IE
$21.00B 591,538.63%
US
$6.51B 183,407.73%
US